Research Article

State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews

Table 2

Bivariate and multivariable analysis for review quality, effect estimates, and scholarly citations.

Dependent variableIndependent variable(s)Bivariate analysis*Multivariable analysis
CoefficientStandard errorCoefficientStandard error

AMSTAR scoreYear of publication0.270.110.0220.210.110.052
BMSC therapy1.580.570.0091.360.560.021

Change in LVEF (%)BMSC therapy1.410.420.002

Yearly Web of Science citationsJournal impact factor0.850.20<0.0010.560.200.007
Authors0.100.040.034
Corresponding author from North America or Europe1.320.33<0.0010.770.320.022
Studies included0.040.020.037
Patients included (100 people)0.070.030.030
RCTs only−1.350.560.023−0.900.430.046

Only independent variables significantly () associated with the dependent variable of interest are reported, but all the following variables were tested: year of publication, authors, North American/European corresponding author, studies included, patients included, RCTs only, type of setting, BMSC therapy, patient-level design, random effects analysis, small study effect testing, subgroup analysis, metaregression, conflict of interests, and funding; a multivariable linear regression model with backward stepwise selection ( for exit 0.10) was used, including in the model all variables significantly () associated with the dependent variable at bivariate analysis; A Measurement Tool to Assess Systematic Reviews (AMSTAR) score; BMSC = bone marrow-derived stem cell; LVEF = left ventricular ejection fraction; RCT = randomized clinical trial.